17:53 IST
BSE
Annual Report
Alivus Life Sciences Annual Report
Alivus Life Sciences Limited has filed its Integrated Annual Report for FY 2025-26 in compliance with Regulation 34(1) of SEBI Listing Regulations.
Alivus Life Sciences Ltd
- Share price
- ₹1,380.00
- Market cap
- ₹16,942 Cr
- Revenue (annual)
- ₹2,552 Cr
- Net profit (annual)
- ₹564.5 Cr
- P/E (TTM)
- 28.1×Sector 47.4×
- Promoter holding
- 74.87%+0.00% QoQ
- FII holding
- 5.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 5Financial Results 4Results Update 2Merger & Restructuring 2Employee Stock Options 2Board Meeting Date 2Annual General Meeting 2Other Announcement 1Debt & Borrowing 1Business Update 1Annual Report 1
Time
1 announcement with these filters